Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
Italy's Beloved Trevi Fountain Hides A Unique Secret That Can Be Explored Underground- Amid growing bipartisan scrutiny of Pete Hegseth, Trump says he 'wouldn't have wanted … a second strike' on alleged Venezuelan drug boat survivors
- Brexit's Effect on New York's Ascent as a Main Monetary Center
- Building a Maintainable Closet: Individual Excursions in Moral Style
- 6 Solid Vehicle Fix Administrations to Keep Your Vehicle in Prime Condition
- The most effective method to Pick the Right Teeth Substitution Choice for You
- Bennu asteroid samples provide clues about solar system origins and 'space gum'
- Creativity Revealed: A Survey of \Making Shocking Looks\ Cosmetics Item
- Ski Resorts Universally: A Colder time of year Wonderland Guide
